KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Operating Income (2016 - 2025)

Medpace Holdings' Operating Income history spans 11 years, with the latest figure at $153.3 million for Q4 2025.

  • For Q4 2025, Operating Income rose 22.25% year-over-year to $153.3 million; the TTM value through Dec 2025 reached $534.9 million, up 19.71%, while the annual FY2025 figure was $534.9 million, 19.71% up from the prior year.
  • Operating Income reached $153.3 million in Q4 2025 per MEDP's latest filing, up from $141.8 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $153.3 million in Q4 2025 to a low of $42.4 million in Q2 2021.
  • Average Operating Income over 5 years is $89.8 million, with a median of $85.6 million recorded in 2023.
  • Peak YoY movement for Operating Income: dropped 0.24% in 2021, then surged 44.89% in 2022.
  • A 5-year view of Operating Income shows it stood at $54.9 million in 2021, then skyrocketed by 39.33% to $76.4 million in 2022, then rose by 14.25% to $87.3 million in 2023, then soared by 43.58% to $125.4 million in 2024, then grew by 22.25% to $153.3 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Operating Income are $153.3 million (Q4 2025), $141.8 million (Q3 2025), and $126.3 million (Q2 2025).